Back to Journals » Therapeutics and Clinical Risk Management » Volume 17

Reexamining Ophthalmic Drugs, Safety and Tolerability in Phase 1 Clinical Trials

Total article views   HTML views PDF downloads Totals
1,034 Dovepress* 1,034+ 49 1,083
Totals 1,034 49 1,083
*Since 21 October 2021

View citations on Google Scholar